1,3-Dimethylbutylamine

1,3-Dimethylbutylamine
(2S)-DMBA	(2R)-DMBA
Names
	Preferred IUPAC name 4-Methylpentan-2-amine
	Other names (4-Methylpentan-2-yl)amine
Identifiers
CAS Number	108-09-8 ;
3D model (JSmol)	Interactive image;
ChemSpider	7620;
ECHA InfoCard	100.003.227
PubChem CID	7908 CID 7908;
UNII	KXP599H5R6 ;
CompTox Dashboard (EPA)	DTXSID4025113 ;
	InChI InChI=1S/C6H15N/c1-5(2)4-6(3)7/h5-6H,4,7H2,1-3H3 Key: UNBMPKNTYKDYCG-UHFFFAOYSA-N; InChI=1/C6H15N/c1-5(2)4-6(3)7/h5-6H,4,7H2,1-3H3 Key: UNBMPKNTYKDYCG-UHFFFAOYAT;
	SMILES CC(C)CC(C)N;
Properties
Chemical formula	C6H15N
Molar mass	101.193 g·mol−1
Density	0.717 g/mL
Boiling point	108–110 °C (226–230 °F; 381–383 K)
Pharmacology
Legal status	BR: Class F2 (Prohibited psychotropics);
Hazards
NFPA 704 (fire diamond)	2 3 0
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

1,3-Dimethylbutylamine (1,3-DMBA, dimethylbutylamine, DMBA, 4-amino-2-methylpentane, or AMP), is a stimulant drug structurally related to methylhexanamine where a butyl group replaces the pentyl group. The compound is an aliphatic amine.

The hydrochloride and citrate salts of DMBA has been identified as unapproved ingredients in some over-the-counter dietary supplements, in which it is used in an apparent attempt to circumvent bans on methylhexanamine. The U.S. Food and Drug Administration (FDA) considers any dietary supplement containing DMBA to be "adulterated". Despite the FDA's opposition, DMBA continues to be sold in the US.

There are no known human safety studies on DMBA and its health effects are entirely unknown.

DMBA is not an agonist of the rodent or human trace amine-associated receptor 1 (TAAR1).